Manufacturers Life Insurance Company, The Cogent Biosciences, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 34,937 shares of COGT stock, worth $310,939. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,937
Previous 35,752
2.28%
Holding current value
$310,939
Previous $301,000
25.25%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding COGT
# of Institutions
170Shares Held
113MCall Options Held
56.7KPut Options Held
40.4K-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct10.5MShares$93.2 Million0.31% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.24MShares$82.2 Million8.19% of portfolio
-
Commodore Capital LP New York, NY7.54MShares$67.1 Million6.92% of portfolio
-
Black Rock Inc. New York, NY7.29MShares$64.9 Million0.0% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA6.96MShares$62 Million9.76% of portfolio
About Cogent Biosciences, Inc.
- Ticker COGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,758,300
- Market Cap $585M
- Description
- Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...